YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (HK:1558) has released an update.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has not yet fulfilled the pre-conditions necessary for the proposed merger with Sunshine Lake Pharma Co., Ltd. As stated in their joint announcement, the merger’s completion is contingent on obtaining various governmental and shareholder approvals, which are still pending. Investors are advised to exercise caution and seek professional advice when dealing with the company’s securities during this uncertain period.
For further insights into HK:1558 stock, check out TipRanks’ Stock Analysis page.
